BackParatek Pharmaceuticals Overview

Paratek Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for PRTK.

Quarterly Cost of Revenue

$4.37M
↓ 10.46% YoY

As of Jun 30, 2023

Annual Cost of Revenue (TTM)

$25.30M
↑ 45.56% YoY

Trailing 12 months ending Jun 30, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin